Use of terbinafine for tinea in Australian Aboriginal communities in the Top End

Australasian Journal of Dermatology

Volumn 44, Issue 4, 2003, Pages 243-249

  Koh, Karen J ^a,b,e   Parker, Colin J ^c   Ellis, David H ^d   Pruim, Bert ^a   Leysley, Loyla ^b   Currie, Bart J ^a,b  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c South Australian Sports Institute   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Dermatophyte; Indigenous Australian; Onychomycosis; Tinea capitis; Tinea corporis; Trichophyton rubrum; Trichophyton tonsurans

Indexed keywords

TERBINAFINE;

ABORIGINE; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG TOLERABILITY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NAIL INFECTION; ONYCHOMYCOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN BIOPSY; TINEA; TINEA CAPITIS; TINEA CORPORIS; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; AUSTRALIA; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; OCEANIC ANCESTRY GROUP; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TINEA; TREATMENT OUTCOME;

EID: 0344687221     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2003.00002.x     Document Type: Article

References (21)

1. Green AC, Kaminski GW. Australian Aborigines and their dermatophytes. Australas. J. Dermatol. 1977; 18: 132-6.
2. Green AC, Kaminski GW. Trichophyton rubrum infections in Northern Territory Aborigines. Australas. J. Dermatol. 1973; 14: 101-20.
3. Currie BJ, Carapetis R. Skin infections and infestations in Aboriginal communities in northern Australia. Australas. J. Dermatol. 2000; 41: 139-43.
4. Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among Aboriginal children. J. Pediatr. Child Health 1995; 31: 245-8.
5. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma, and rheumatic fever. Lancet 1996; 347: 1271-2.
6. CARPA. Standard Treatment Manual, 3rd edn. Alice Springs: Central Australian Rural Practitioners Association, 1997; 203.
7. Hofmann H, Brautigam M, Weidinger G, Zaun H. Treatment of toenail onychomycosis: A randomized double blind study with terbinafine and griseofulvin. Arch. Dermatol. 1995; 131: 919-22.
8. Faergemann J, Andresen C, Hersle K, Hradil E, Nordin P, Kaaman T, Molin L, Pettersson A. Double blind parallel group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J. Am. Acad. Dermatol. 1995; 32: 750-3.
9. Haneke E, Tausch I, Brautigam M, Weidinger G, Welzel D. Short duration treatment of fingernail dermatophytosis. A randomized double blind study with terbinafine and griseofulvin. J. Am. Acad. Dermatol. 1995; 32: 72-7.
10. NSW Burns Management Working Group. Lund and Browder Chart. Public Health Division, Management Guidelines for People with Burn Injury. Sydney: NSW Health Department, 1996; 3.
11. Green AC. Australian Aborigines and ringworm (tinea). Australas. J. Dermatol. 1998; 39: 192-4.
12. Sehgal VN, Jain S. Onychomycosis: Clinical perspective. Int. J. Dermatol. 2000; 39: 241-9.
13. Lim JT, Chua HC, Goh CL. Dermatophyte and non-dermatophyte onychomycosis in Singapore. Australas. J. Dermatol. 1992; 33: 159-63.
14. Pontes ZB, de Lima EO, Oliveira NM, Dos Santos JP, Ramos AL, Carvalho MF. Onychomycosis in Joao Pessoa City, Brazil. Rev. Argent. Microbiol. 2002; 34: 95-9.
15. Roberts DT. Onychomycosis: Current treatment and future challenges. Br. J. Dermatol. 1999; 141 (Suppl. 56): 1-4.
16. White JE, Perkins PJ, Evans EGV. Successful 2 week treatment with terbinafine (Lamisil®) for moccasin tinea pedis and tinea manuum. Br. J. Dermatol. 1991; 125: 260-2.
17. Farag A, Taha M, Halim S. One week therapy with oral terbinafine in cases of tinea cruris/corporis. Br. J. Dermatol. 1994; 131: 684-6.
18. Hoy W, Kelly A, Jacups S, McKendry K, Baker P, MacDonald S et al. Stemming the tide: Reducing cardiovascular disease and renal failure in Australian Aborigines. Aust. NZ J. Med. 1999; 29: 480-3.
19. Evans EG, Seaman RA, James IG. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections. Br. J. Dermatol. 1994; 130: 83-7.
20. Humphrey KM, Cork MJ, Haycox A. A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice. Br. J. Dermatol. 1998; 139: 660-4.
21. Gupta AK, Lambert J. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA. Int. J. Dermatol. 1999; 39 (Suppl. 12): 53-64.